Copertina

TP53 mutations in urothelial carcinoma: not all one and the same†

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alexis R Barr, Amy Burley, Anna Wilkins
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	The Journal of Pathology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma
di: Kaifeng Jin, et al.
Pubblicazione: (2024)

DNA ‐hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation
di: Yasunobu Mano, et al.
Pubblicazione: (2025)

Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary†
di: Hannah C Beird, et al.
Pubblicazione: (2024)

Tubal ligation exacerbates ovulation‐driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin
di: Kanchana Subramani, et al.
Pubblicazione: (2026)

Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells
di: Burles A Johnson, et al.
Pubblicazione: (2025)

Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma
di: Spencer D Martin, et al.
Pubblicazione: (2025)

Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
di: Csilla Olah, et al.
Pubblicazione: (2025)

Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid
di: Elin Schoultz, et al.
Pubblicazione: (2025)

Use of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma
di: Jeffrey S. Ross, et al.
Pubblicazione: (2024)

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†
di: Tibor Szarvas, et al.
Pubblicazione: (2024)

A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing
di: Miriam Angeloni, et al.
Pubblicazione: (2024)

Synchronous endometrial/cervical and ovarian/fallopian tube carcinoma: a genome‐wide mutation analysis
di: Lihong Li, et al.
Pubblicazione: (2025)

PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases
di: Keisuke Goto, et al.
Pubblicazione: (2024)

The significance of PAX5 in Merkel cell carcinoma
di: Emil Chteinberg, et al.
Pubblicazione: (2025)

Cell state dynamics during early stages of serous endometrial carcinoma
di: Andrea Flesken‐Nikitin, et al.
Pubblicazione: (2025)

An oncogenic role for EBV ‐encoded BILF1 in nasopharyngeal carcinoma
di: Anna KC Wong, et al.
Pubblicazione: (2026)

Exploring adenoid basal carcinoma to squamous cell carcinoma of the uterine cervix transformation using spatial transcriptomics
di: Ruyi Ma, et al.
Pubblicazione: (2026)

Clinicopathological characteristics of patients with inoperable non‐small cell lung cancer harboring circulating NRF2 pathway mutations
di: Jouni Härkönen, et al.
Pubblicazione: (2026)

Cellular origins of mucinous ovarian carcinoma
di: Nicola S Meagher, et al.
Pubblicazione: (2025)

Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma
di: Jing Yang, et al.
Pubblicazione: (2024)

Clinicopathological and molecular spectrum of patients with germline SUFU mutations: A case series
di: Mashiro van Dal, et al.
Pubblicazione: (2024)

ATM immunohistochemistry as an effective screening method for POLE variants among endometrial carcinomas lacking mismatch repair deficiency and p53 abnormalities
di: Xinyi Huang, et al.
Pubblicazione: (2026)

Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
di: Lucas‐Alexander Schulte, et al.
Pubblicazione: (2025)

DNA methylation patterns are influenced by Pax3 :: Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models
di: Wenyue Sun, et al.
Pubblicazione: (2025)

Genetic and epigenetic alterations in precursor lesions of endometrial endometrioid carcinoma
di: Osamu Gotoh, et al.
Pubblicazione: (2024)

Aberrant TERT expression: linking chronic inflammation to hepatocellular carcinoma†
di: Rui Dong, et al.
Pubblicazione: (2025)

Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation
di: Thibault Kervarrec, et al.
Pubblicazione: (2024)

PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas
di: Tamara Cubiella, et al.
Pubblicazione: (2024)

Genetic landscape of non‐ UV ‐induced cutaneous squamous cell carcinomas
di: Carmen Al Youssef, et al.
Pubblicazione: (2025)

CLEC14A correlates with neutrophil infiltration in hepatocellular carcinoma and mediates neutrophil recruitment across liver endothelial cells
di: Joanne M O'Rourke, et al.
Pubblicazione: (2026)

Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
di: Natalia Gorbokon, et al.
Pubblicazione: (2024)

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
di: Michael Menzel, et al.
Pubblicazione: (2024)

Identifying therapeutic targets in low‐grade serous ovarian carcinomas with no specific molecular profile
di: Kathleen I Pishas, et al.
Pubblicazione: (2026)

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
di: Tanjina Kader, et al.
Pubblicazione: (2025)

Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts
di: Stefan J Hutten, et al.
Pubblicazione: (2024)

NMRK2 is an efficient diagnostic indicator for Xp11.2 translocation renal cell carcinoma
di: Huayi Feng, et al.
Pubblicazione: (2024)

A rare form of metastatic breast carcinoma mimicking lymphangioma circumscriptum
di: Zacaria Jr. B. Pario, et al.
Pubblicazione: (2024)

Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model
di: Yanjiang Chen, et al.
Pubblicazione: (2024)

Multiregion exome sequencing indicates a monoclonal origin of esophageal spindle‐cell squamous cell carcinoma
di: Yulu Wang, et al.
Pubblicazione: (2024)

Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix
di: Baoyue Pan, et al.
Pubblicazione: (2024)